BACKGROUND: Antipyretic therapy Is commonly prescribed for patients with Infection, but studies of Its Impact on clinical outcomes have yielded mixed results. No data existtocharacterize the useof antipyretic medications in patients withsevere sepsisor septic shock.
A ntipyretic medications are commonly prescribed for hospitalized patients.P Despite the frequency of fever in humandisease,however, very little is understood aboutthe role of antipyretics in the treatment of fever with coexisting infection.' Observational datasuggest that fevermaybe important for immune function, and animal data corroborate those findings, suggesting reduced mortality in subjects allowed to mount a normal febrile response. 4 • 12 Clinical trials exploring antipyretic therapy in critically ill patients have yielded mixed results.P't? Fever can increase the metabolic demands in this population by over 40% and can degrade left ventricular performance.":" Febrile-range hyperthermia also increases lunginjury in experimental models of pneumonia.P" Some clinicians have suggested that certainpatients may not tolerate the tachycardia, increased minute ventilation, and metabolic loadof fever and have proposed that these patients may benefit from antipyretic therapy. 19, 22 Despite the controversy, no evidence-based guidelines for the treatment of fever in life-threatening illness exist.
Previous articles have described orders written for antipyretic therapy and doses administered, but, to our knowledge, no study has investigated clinicalfactors associated with antipyretic medication administration in febrile patients,':' The objective of this study was to characterize clinical factors associatedwith antipyretic therapy in a cohortof hospitalized patients with gram-negative severe sepsisor septicshock.
Author information provided at end of text.
Methods

DESIGN
Weconducted a retrospective cohort study of febrile patients withgram-negative bacteremia who werehospitalized at an llll-bed academic medical center between January 2002 andFebruary 2008 (N =241).Allincluded patients had fever (temperature ;883 "C)within 24 hours of blood culture and met criteria for severe sepsis or septic shockby ICD-9
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The AnnalsofPharmacotherapy • 2011 October, Volume 45 • 1207 criteria, as reported by Martin et al. and Angus et al. 23 ,24 The data set was restricted to gram-negative bacteria because of the presumed homogeneity in the cause of fever with gramnegative bacteremia (eg, lipopolysaccharide release). Furthermore, gram-negative bacteremia is less likely to represent false-positive contamination, as may occur with gram-positive organisms. Patients who had simultaneous blood cultures that grew gram-positive or fungal organisms were excluded. Figure I shows the flow diagram of study participants. Patients were included from all inpatient hospital services (including emergency department [ED] , intensive care units [ICOs] , and ward beds). Patients were excluded for factors that might bias the likelihood of their being treated with antipyretic medications at the time of sepsis diagnosis, including cirrhosis, elevation in hepatic enzymes (aspartate aminotransferase or alanine transaminase >5 times the upper limit of normal or total bilirubin >3 times the upper limit of normal), acute brain injury (including traumatic brain injury, stroke, or intracerebral hemorrhage) diagnosed during hospitalization before diagnostic blood culture, and allergy to acetaminophen. Patients were excluded for incomplete data only if the chart did not reflect a dispo- sition or if insufficient information was available to apply exclusion criteria. For patients with more than 1 episodeof severesepsiswith bacteremia duringthe studyperiod,only the first occurrence was considered. All medication orders and medication administration history werecollectedfor drugs containing acetaminophen or ibuprofen between the indextime and 72 hoursafterthe index time. Index time was defined as the time at which a bloodsample wascollected fora culture thatyielded a gramnegative organism. Dataon patient temperatures, mechanical ventilation, vasopressor use,treatment in an ICUor ED, and demographic factors (age, sex, skillednursing facility residence,admission through ED) weregathered. Vasopressors weredefined as norepinephrine, dopamine, or phenylephrine administered by continuous infusion (excluding agents typically used for their inotropic effects, including dobutarnine, rnilrinone, and epinephrine). Features of the medical history, home medications, and other therapeutic interventions (including antibiotics, drotrecogin alfa [activated], corticosteroids, immunosuppressive medications) werealso recorded. Inappropriate antibiotics were definedas antimicrobial therapy thatwaseithernot initiated within 24 hours of index time or therapyto which in vitro sensitivity testing subsequently showed thepathogen to beresistant.
Each patient's hospital course for the 72 hours immediately following the index time was dividedinto sequential 8-hour time periods, and the maximum temperature attained over each period was recorded, defining the presence or absence of fever. Each time periodwas then evaluated for the presence of each of the clinical factors (ie, mechanical ventilation, vasopressor use, ICU residence) at any pointduringthat 8-hourperiod. Antipyretic orders and doses administered were recorded for the entire 72 hours, and then were divided into the appropriate 8-hour periods. Of the 2169periodsincluded, no data weremissing.
Fever was definedas a body temperature greaterthan or equal to 38.3 ·C, as recommended by a consensus of the American College of Critical Care Medicine and the Infec-tiousDiseases Society of America.s Modified AcutePhysiologic and Chronic Health Evaluation, second revision (APACHE-II) scoreswere calculated at the index time because we were unable to assign accurately a Glasgow Coma Scale score to each patient,and not all patients had all laboratory values available at the time the culture was collected (the most extreme values over 24 hours before and afterindextime were used)."
The Washington University HumanResearch Protection Office approved this study protocol and granted a waiver of informed consent.
STATISTICAL METHODS
Generalized estimatingequations (GEEs) were used to assess the relationship of various factors with antipyretic Antipyreticsin SevereSepsisand SepticShock exposure, because GEEs allow analysis using both independent (between patients) and repeated measures (withinpatient) data. Univariable analysis was initially performed usingsinglepredictor variables to assess significance of relationships. The subsequent multivariable GEE analysis incorporated factors foundto be relevant in univariable analysis and calculated the adjusted odds ratios controlling for measured covariates.
The GEE modelused a binomial probability distribution with a logit link function and an exchangeable correlation structure, similarto logistic regression. Predictorvariables were included in a main effects explanatory model. All febrile episodes were included,none of the included variables contained missing data, and each variable was tested for collinearity. Interaction variables with potential physiologic plausibilitywere placed in the model, but none was found to be independently significant, so they were removed from the final model. Data were analyzed using PASW Statistics 18.0(ffiM Corp.,Somers,NY). Table 1 shows characteristics of patients included in the study group (N =241). Of the 801 doses of antipyretic medication administered for the entire study cohort, only 40 (5.0%) were ibuprofen. Each patient contributed a differentnumberof febrile time periods,with 84 (34.9%) patients contributing a single time period, 127 (52.7%)contributing 2-5 time periods, and 30 (12.4%) contributing 6 or moretime periods.
Results
ADMINISTRATION OF ANTIPYRETIC THERAPY
Of the time periods in which fever was observed (n = 673), a conditionalorder for acetaminophen or ibuprofen was present in 494 (73.4%). Antipyretic therapy was administered in only 283 febrile time periods (42.1 % of periods where fever was observed). Afebrile patients were treated with acetaminophen or ibuprofen in 281 of 1601 periods (17.6%). The likelihood of being treated with an antipyretic medication was unrelated to time of day or nursing shift (42.7% day shift, 39.0%eveningshift,44.9% night shift; p =0.43).Univariable comparison is shown in Table 2 (p values test the hypothesis that the parameter does not differbetween the 2 groups). Figure 2 shows the proportion of patientsbeing administered an antipyretic drug for fever stratified by magnitude offever, with 50% offevers being treated at 38.9 ·C. Patientswith fever greaterthan 39.3·C were less likely to receive an antipyretic medication than those with feversof a lesser magnitude. Figure3 showsthe relationship between treatment with antipyretic medication and time since diagnosis of sepsis. Patients were most likely to receive antipyretic therapy shortly after initial diagnosis.
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The Annals of Pharmacotherapy This analysis intended to describe current antipyretic therapy practice in patients with severe sepsis and septic shock and to identify patterns in patients who are treated An explanatory logistic regression model was constructed using GEEs to determine the influence of underlying factors on administration of antipyretic medications in febrile patients. Factors associated with administration of antipyretic medications were temperature magnitude, time after diagnosis of sepsis, surgery during hospitalization, death in the subsequent 36 hours, and mechanical ventilation ( Table 3 ). The effect magnitude is given by the adjusted odds ratio . For instance, the odds of receiving an antipyretic medication increase by more than twice (OR 2.11) for each degree increase in the maximum temperature , when adjusted for the other covariates in the model. Temperature was included as a linear variable, despite the apparent nonlinearity of the probability (Figure 2 ), because so few cases of very high temperatures were included, and stratifying maximum temperature into categories did not change the parameter significance .
with antipyretic medications. One of the interesting findings is that there was wide practice variability in which patients are treated, and little of that variability can be explained by the measured patient or provider factors . Those factors that are predictive seem to have little correlation with physiologically plausible theories upon which some recommend fever therapy.19,2Z Such variability in prescribing and administration is likely a reflection of the absence of strong evidence-based guidelines with which to guide decision making about fever treatment in sepsis. If antipyretic therapy were shown definitively to affect sepsis outcomes , however, most would agree that wide practice variation is undesirable.
Data conflict on the potential protective role of fever in severe human infections.":" Clearly, failure to mount fever is a marker for worse clinical outcomes, but whether therapeutically attenuating fever has a similar effect is unclearP'Z9 Furthermore, understanding clinicians' choices in treating patients with fever may lend new insight to factors that playa role in the unique risk-benefit tradeoff for a therapy of uncertain effectiveness.
For this series, patient data were divided into 8-hour time periods for the analysis. Isaacs et al. reported on the practice patterns of clinicians ordering antipyretic medication; in their report, 94% of as-needed orders specified a time period for redosing of 6 hours or less.' Furthermore, nurses often work in shifts of 8-12 hours and are the primary decision-maker for whether a febrile episode for any given patient is treated with an antipyretic. Body temperature for patients on a general ward is measured at least every 8 hours. We intended to identify a time period small enough to associate an antipyretic dose with a particular febrile episode, with a temperature being measured during each time period, allowing adequate time for a fever to be recognized and treated by the nursing staff. Although only 42% of patients with fever were treated with an antipyretic drug during the study period, that factor was not strictly a function of the fever magnitude. Surprisingly, patients with very high temperatures were less likely to receive antipyretic therapy than those with less extreme temperatures. This factor may be a reflection of exclusion criteria, in which patients with contraindications to acetaminophen dosing were excluded only at the time blood samples for cultures were drawn, which may have included some patients in our analysis who developed liver dysfunction after the first 24 hours. This finding could also include patients who manifested very high temperatures that had already proven to be refrac- tory to antipyretic therapy, with subsequent therapy deemed futile. Four of the 14 patients (29%) with sustained (in more than 2 time periods) temperatures over 40°C were administered an antipyretic during their first episode of fever, but not during subsequent similarly extreme fever episodes.
Some patients (17.6%) received an antipyretic drug when they had no fever. These medications were likely given for another indication, such as pain or other discomfort. From these data, one could also conclude that some of the doses of antipyretic medications given to febrile patients were for indications other than fever, which would suggest that even fewer cases of fever arebeing treated.
Treatment of fever is an individualized clinical decision. Many febrile patients have orders for antipyretic agents, but a large percentage do not receive therapy for a given febrile episode. Physiologically, some patients may have clinical factors based on evidence of shock, tissue hypoperfusion, or risk factors for myocardial ischemia that favor antipyretic treatment. Some of these factors may drive clinicians to seek to attenuate tachycardia or other physiologic sequelae, such as increased CO 2 production, by administering antipyretics. The metabolic load of fever is significant, Antipyretics inSevere Sepsis andSeptic Shock but patients expected to withstand the demands may benefit from forgoing antipyretic treatment" S , 19, 30 If there is benefit to treating fever, that benefit is probably realized early when patients are most unstable, which could explain the shift toward early treatment after the diagnosis of sepsis.
The negative association between mechanical ventilation and antipyretic therapy is notable, because mechanical ventilation is likely a surrogate not only for respiratory failure, but also for sedation. Sedated patients seem less uncomfortable and are less likely to receive antipyretic therapy. Patients with respiratory failure could be thought to have more metabolic load that might justify more aggressive antipyretic therapy, but this is not the relationship that is observed. Despite the relationship with mechanical ventilation, no such relationship exists with vasopressor use, which does not necessarily alter the perception of discomfort.
Surgical patients seem significantly less likely to receive antipyretic medications than nonsurgical patients. This finding corroborates an observation that antipyretic therapy is associated with the admitting service" Because we did not specifically control for the admitting service in our analysis, we suspect that the surgical finding is actually a practice variation. There seems to be a trend in our institution whereby surgical patients are less likely to receive antipyretic medications for fever than nonsurgical patients, although there is no clear physiologic basis for this observation. We do not have data on which patients were fasting secondary to postoperative ileus, but this could be one explanation for the difference between surgical and nonsurgical patients. (Note that this study was performed prior to the availability of intravenous acetaminophen.) Most neurosurgical patients would have been excluded from our analysis. Another interesting finding was the strong association between treatment with an antipyretic drug and death. From this retrospective cohort it is impossible to know whether end-of-life care does not include antipyretic therapy or whether antipyretic therapy decreases mortality. It is possible that patients with massive cytokine release exhibit factors that make them less likely to receive antipyretic therapy not adjusted by other covariates in the multivari-able model. The number of patients who died within 36 hours of antipyretic therapy was small (n = 28) relative to the size of the entire cohort.
The last factor that seems to influence the likelihood of receiving antipyretic therapy is the time since diagnosis of severe sepsis or septic shock. As expected, the likelihood of therapy decreases as the acute phase of illness resolves. If there are benefits to antipyretic therapy, those benefits may be early in shock attenuation and reversal of respiratory failure. Figure 3 shows that not only does the rate of antipyretic administration fall over the first 32 hours, but that rate begins to climb again later. As some patients improve, those who are persistently febrile may be deemed sicker in the opinion of treating clinicians and thus may be given antipyretic therapy for treatment of shock. Many of these critically ill patients were treated during the entire study, but because more patients who were febrile but less ill were included in the 8-to 32-hour period, the rate of treatment appears to be lower. One of the nonsignificant trends that deserves comment is the association between male sex and antipyretic therapy. This finding contradicts an earlier report that male sex was associated with an increased likelihood for an order for antipyretic therapy in univariable analysis, although the association was nonsignificant in multivariable logistic regression.' Intuitively, it does not make sense that this single demographic factor influences the probability of being treated for fever, even though the effect size seems modest (adjusted OR 0.66, p =0.052). There have been reports that female sex is protective in various inflammatory states, so it is possible that fewer females required treatment for fever because clinical evidence of life-threatening inflammation (ie, severe shock, organ failure, respiratory failure) was absent.":" This interesting finding should be explored in other controlled analyses as a factor potentially confounding analysis, and the effect of therapy should be explored in subgroup analysis in prospective clinical trials.
One of the findings of this analysis is that specific administrative and demographic factors do not influence the likelihood of being treated with antipyretic medications.
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Antipyreticsin SevereSepsisand SepticShock
Patients in the ICU may have more actual interventions and more personalized nursing staff, but critical care does not predict the likelihood of fever therapy. That observation is especially interesting because it likely means that the clinical decisions leading to antipyretic administration by nurses in the ICU are similar to those made by nurses on wards and in the ED.
The greatest limitation of this cohort study is the retrospective nature of the data collection. As such, we are limited to times of medication administration as documented in the medical record and body temperatures as recorded. It is possible that some doses are recorded at a time later than actually administered, but this is a recognized factor in retrospective research.
Another limitation is the inability to ascertain the indication for administration of antipyretic drugs. There is no mechanism to verify that antipyretic medications are actually administered for fever, but the rate of antipyretic medication administration in afebrile time periods was only 17.6%, so most doses were presumably given in response to fever. Although previous investigators have reviewed 60% .,.~. medical recordsto try to retrievethis information,they noted that such data were rarely included in medical notes, which agrees with our practiceexperience.' To identify a cohort of patients with no biases influencing the administration of antipyretics, we excluded certain groups that either had an indication (eg, brain injury) or contraindication (eg, liver disease, allergy to acetaminophen) to antipyretics for fever control. Those exclusions, while valid, may limit the externalvalidity, and patientpopulations that contain these excluded patients are likely to have either a higher or lower incidence of antipyretic administration.Another limitation is the single-centerdesign of our study,but we suspect that providers in other institutions likely use factors similar to those used in our institution to guide their antipyretic therapydecisions.
Finally,factors that may influence the administrationof antipyretic medications are broad. We investigated several potential factors, but others likely exist that are not contained in our data set. For instance, the admitting service caring for patients was not explored rigorously, but has been shown previously to have significant impact on the likelihood of antipyretic medications being ordered. As such, only measured covariates were included in our regression model, and unmeasured covariates undoubtedly still exist.
In this cohort of 241 patients, fever was observed in 673 (31.0%) time periods, and clinical factors seemed to influence which patients received antipyretic therapy. Demographic, administrative, and severity of illness markers do not seem to impact likelihoodof therapy. Although this series sheds light on some factors that cliniciansuse to deter- 
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